Dutch economic value of radium-223 in metastatic castration-resistant prostate cancer
ML Peters, C De Meijer, D Wyndaele… - … health economics and …, 2018 - Springer
Background The treatment of metastatic castration-resistant prostate cancer has changed
with the introduction of radium-223, cabazitaxel, abiraterone and enzalutamide. To assess …
with the introduction of radium-223, cabazitaxel, abiraterone and enzalutamide. To assess …